BioSpace News Archive

Navidea to Host Moderated Q&A Webcast with Management June 21, 2018

Navidea Biopharmaceuticals announced today that it will hold an online Question & Answer (Q&A) Session focused on Navidea’s clinical progress in Nonalcoholic Steatohepatitis (NASH) with Jed Latkin, Chief Financial and Operating Officer, and Fred Cope, Ph.D., Chief Scientific Officer of Navidea

June 14, 2018
·
2 min read
Biotech Bay

TRC Healthcare Partners With athenahealth To Provide Access To Prescriber’s Letter Excerpts Through The Epocrates Mobile App

The #1 Medical App for Clinicians Will Offer Complimentary Access to Newsworthy Clinical Findings and Evidence-Based Drug Therapy Recommendations

June 14, 2018
·
3 min read
Policy

Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.

Kyros Law Offices is alerting individuals that have suffered serious side effects from taking Invokana that it is investigating filing legal claims seeking compensation for their injuries.

June 14, 2018
·
1 min read
Deals

Ardent Health Services Announces Pricing Of Senior Notes Offering

Ardent Health Services announced that AHP Health Partners, Inc. has priced $475 million aggregate principal amount of 9.75% senior unsecured notes due 2026 (the “Notes”) in a private offering.

June 14, 2018
·
4 min read
Drug Development

SanBio’s US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)

The SanBio Groupn hereby announces that the US-based phase 1/2a clinical trial of SB623 for the treatment of chronic motor deficit from ischemic stroke

June 14, 2018
·
1 min read
FDA

Dr. Reddy’s Laboratories Announces USFDA Final Approval and Launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching Buprenorphine and Naloxone Sublingual Film

June 14, 2018
·
9 min read
BioForest

Emergency Departments Help Close Gaps in Opioid Abuse and Addiction Treatment

Medication Assisted Treatment Lowers Risk of Fatal Overdoses, Improves Long-Term Outcomes

June 14, 2018
·
5 min read
Deals

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2018

Zimmer Biomet Holdings, Inc. announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2018.

June 14, 2018
·
1 min read
Drug Development

DermTech and Harvard Publish Two Clinical Studies at IID

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl.

June 14, 2018
·
2 min read
Policy

Med Associates Provides Notice of Data Security Incident

Med Associates, Inc. processes claims for medical providers located in and around Albany, NY.

June 14, 2018
·
2 min read